QuintilesIMS:通过合并造就领先的全球一体化信息和技术型医疗服务提供商
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 康涅狄格州丹伯里与北卡州三角研究园 (美国商业资讯)–Quintiles IMS Holdings, Inc. (NYSE:Q)今日宣布,公司已经成功地完成了IMS Health Holdings, Inc. (NYSE:IMS)与Quintiles...
View Article免疫细胞治疗剂‘Immuncell-LC’,延长胶质母细胞瘤的无进展生存时间1.5倍
韩国首尔 (美国商业资讯)–以“以韩国人中最新确诊的胶质母细胞瘤患者为对象,并用标准疗法和基于CIK诱导杀伤细胞的细胞免疫治疗法的第三期随机临床试验(Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in...
View Article海外投資家が注目するがん治療日本独自技術のANK免疫細胞療法に焦点:リンパ球バンク株式会社
東京 (ビジネスワイヤ) – がん免疫治療で先進的な取り組みをしている京都大学発のベンチャー企業、リンパ球バンク株式会社(本社:東京都千代田区、代表取締役:藤井真則)が、海外投資家から注目されています。 このSmart News Release(スマート・ニュース・リリース)にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから:...
View ArticleKymab and EpimAb Biotherapeutics Announce Multi-Target, Bispecific Antibody...
CAMBRIDGE, United Kingdom & SHANGHAI Kymab, a leading human monoclonal antibody biopharmaceutical company, and EpimAb Biotherapeutics, an emerging biopharmaceutical company specializing in...
View ArticleReplicor公司将在AASLD 2016上披露最新出炉的乙肝病毒临床数据
纽约市 (美国商业资讯) — 致力于治愈慢性乙型肝炎和丁型肝炎患者的私营生物制药公司Replicor Inc.今天宣布,该公司最新的REP 401临床试验中期分析初步数据已被美国肝病研究学会(AASLD)选中,在该学会年会的最新出炉摘要分会场上进行口述呈报,此次会议将于2016年11月11-15日在美国波士顿召开。 REP...
View Articleズィマジェン、ソフトバンク主導のシリーズB資金調達で1億3000万ドルの確保を発表
米カリフォルニア州エメリービル (ビジネスワイヤ) — 生物学の力を解き放つ技術企業のズィマジェンは本日、ソフトバンクグループ(TOKYO:...
View ArticleNitto Denko Avecia Inc. Acquires the Businesses of Irvine Pharmaceutical...
MILFORD, Mass. Nitto Denko Avecia Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio...
View ArticleCovance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence...
BURLINGTON, N.C. Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that Covance Drug Development (“Covance”) has been awarded the 2016 Frost & Sullivan Asia...
View ArticleZymergen在软银领投的B轮融资中筹得1.3亿美元资金
加州埃默里维尔 (美国商业资讯)–释放生物学潜能的技术公司Zymergen今日宣布,公司在由软银集团(SoftBank Group)(TOKYO: 9984)领投的B轮融资中筹集了1.3亿美元。参加此轮融资的投资者还包括此前的领投投资者Data Collective (DCVC)以及再次投资者True Ventures、AME Cloud Ventures、DFJ、Innovation...
View ArticleCertara Establishes Phoenix® PK/PD Centers of Excellence in China and Japan
PRINCETON, N.J. Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Peking Union...
View ArticlePharmgate Concludes Merger With ProtaTek International, Inc.
WILMINGTON, N.C. Pharmgate LLC today announced that it has successfully concluded its merger with ProtaTek International, Inc. which will continue to operate as a wholly owned subsidiary. Former...
View ArticleDr. Reddy’s to Release Q2 FY17 Results on Oct 25, 2016; Earnings Call Slated...
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Second Quarter ended September 30, 2016 on Tuesday, October 25, 2016 after the Board...
View ArticleIVF-Worldwide.com Launches Virtual Academy of Egg Health
HONG KONG & SALT LAKE CITY Today, at the American Society for Reproductive Medicine (ASRM) 2016 Scientific Congress & Expo, IVF-Worldwide, the largest and most comprehensive in-vitro...
View ArticleOrthocell Receives Approval for Human Nerve Regeneration Study Using CelGro®
PERTH, Australia Regenerative medicine company Orthocell has been granted ethics approval for a human study examining the effectiveness of its CelGro® collagen medical device, to guide and promote...
View ArticleGynesonics Announces Early Completion of Enrollment in the SONATA FDA...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the...
View ArticleClinigen Launches Japanese Business to Strengthen Asian Presence
TOKYO Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or ‘the Group’), the global pharmaceuticals and services group, has launched its Japanese business with the opening of an office in Tokyo, Japan. The...
View ArticleTakeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on...
View ArticleQuintilesIMS被Frost & Sullivan评选为2016年亚太区年度CRO公司
新加坡 (美国商业资讯) — QuintilesIMS因其业界领先地位和服务交付卓越性,今天被领先的商业调研和咨询公司Frost & Sullivan评选为亚太区年度合同研究组织(CRO)。Frost & Sullivan的选择中所采用的评估是昆泰与IMS Health于本月初合并之前开展的。 Smart News...
View ArticleNew Data from Reach2HD Trial Presented at American Neurological Association...
MELBOURNE, Australia Prana Biotechnology Ltd (ASX:PBT/NASDAQ:PRAN) is pleased to announce that further analysis of the cognitive results of its Reach2HD trial to treat Huntington Disease was...
View Article